These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 368769)

  • 41. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis.
    Hory B; Saint-Hillier Y; Perol JC
    Nephron; 1983; 33(1):71. PubMed ID: 6339968
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostacyclin administration during cardiopulmonary bypass in man.
    Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
    Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of blood loss in dialysers with DEAE-cellulose membranes does not require increased doses of heparin.
    Ward RA; Schmidt B; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(10):1140-5. PubMed ID: 8272230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis.
    Dibble JB; Kalra PA; Orchard MA; Turney JH; Davies JA
    Thromb Res; 1988 Feb; 49(4):385-92. PubMed ID: 2454514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostacyclin in Falciparum malaria.
    Weston MJ; Jackman N; Rudge C; Bowles J; Brady C; Bielawska C; O'Grady J
    Lancet; 1982 Sep; 2(8298):609. PubMed ID: 6125752
    [No Abstract]   [Full Text] [Related]  

  • 46. Developments in dialysis for acute renal failure.
    Richards NT; Mansell MA
    Br J Hosp Med; 1986 Mar; 35(3):190-2. PubMed ID: 3527316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
    Maurin N
    Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
    [No Abstract]   [Full Text] [Related]  

  • 48. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
    Ryan KE; Lane DA; Flynn A; Shepperd J; Ireland HA; Curtis JR
    Thromb Haemost; 1991 Sep; 66(3):277-82. PubMed ID: 1745997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure.
    Fiaccadori E; Maggiore U; Parenti E; Giacosa R; Picetti E; Rotelli C; Tagliavini D; Cabassi A
    Nephrol Dial Transplant; 2007 Feb; 22(2):529-37. PubMed ID: 17071958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostacyclin (PGI2).
    Davies SC; Machin SJ
    Intensive Care Med; 1983; 9(2):49-52. PubMed ID: 6343445
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparin neutralizing activity in patients with renal disease on maintenance haemodialysis.
    Aronstam A; Dennis B; Friesen MJ; Clark WF; Linton AL; Lindsay RM
    Thromb Haemost; 1978 Jun; 39(3):695-700. PubMed ID: 309192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental assessment of prostacyclin in the harvesting of kidneys for transplantation.
    Mundy AR; Bewick M; Moncada S; Vane JR
    Transplantation; 1980 Oct; 30(4):251-5. PubMed ID: 7003843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of ticlopidine and heparin on hemodialysis in dogs.
    Gross ML; Bush H; Weinger R; Hamburger RJ; Flamenbaum W
    J Lab Clin Med; 1982 Dec; 100(6):887-95. PubMed ID: 7142790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
    Longmore DB
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin and prostacyclin.
    Camici M; Evangelisti L
    Angiology; 1989 Apr; 40(4 Pt 1):294-9. PubMed ID: 2650580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
    Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
    Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
    Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of acute pulmonary hypertension by prostacyclin.
    Borchert J; Franke J; Lichey J
    Cor Vasa; 1980; 22(4):281-7. PubMed ID: 7004773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.